Bellwether Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4
Closed -$1.56K 271
2025
Q2
$1.56K Hold
4
﹤0.01% 510
2025
Q1
$1.74K Hold
4
﹤0.01% 442
2024
Q4
$1.48K Buy
+4
New +$1.67K ﹤0.01% 465
2023
Q2
Sell
-4
Closed -$1.84K 202
2023
Q1
$1.84K Hold
4
﹤0.01% 348
2022
Q4
$2.05K Sell
4
-1
-20% -$508 ﹤0.01% 355
2022
Q3
$2K Buy
5
+1
+25% +$478 ﹤0.01% 382
2022
Q2
$1K Hold
4
﹤0.01% 353
2022
Q1
$1K Hold
4
﹤0.01% 498
2021
Q4
$1K Sell
4
-4
-50% -$1.68K ﹤0.01% 526
2021
Q3
$2K Buy
8
+4
+100% +$1.52K ﹤0.01% 465
2021
Q2
$1K Hold
4
﹤0.01% 395
2021
Q1
$1K Hold
4
﹤0.01% 370
2020
Q4
$1K Buy
+4
New +$1.23K ﹤0.01% 311

Other funds holding ELV

Bellwether Advisors's ELV Position: Q3 2025 in Review

Bellwether Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 4 shares — an estimated $1.56K sold.

Bellwether Advisors first reported a position in ELV in Q4 2020 and held it in 13 quarters. The position peaked at $2.05K in Q4 2022. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Bellwether Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Bellwether Advisors sold 4 Elevance Health shares in Q3 2025, an estimated $1.56K.
  • Bellwether Advisors first reported a position in Elevance Health in Q4 2020 and held it in 13 quarters.
  • Bellwether Advisors's Elevance Health position peaked at $2.05K in Q4 2022.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Bellwether Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.